
Journal of Organometallic Chemistry p. 197 - 202 (2012)
Update date:2022-07-29
Topics:
Qiao, Weixia
Shao, Mingbo
Wang, Jianhui
The reaction of a ruthenium carbide complex RuCl2(C:) (PCy 3)2 with [H(Et2O)x] +[BF4]- at a molar ratio of 1:2 produced a two-core ruthenium carbene complex {[RuCl(CHPCy3)(PCy 3)]2(μ-Cl)3}+·[BF 4]- (8) in the form of a yellow-green crystalline solid. After a ligand exchange reaction of 8 with LiBr, a bromide ruthenium carbene complex {[RuBr(CHPCy3)(PCy3)]2(μ-Cl) 3}+·[BF4]- (9) was obtained as a crystalline solid. Catalytic studies showed that both 8 and 9 are selective catalysts for ring closing metathesis of unsubstituted terminal dienes. More importantly, no isomerized byproduct was observed when 8, or 9 was used as the catalyst at an elevated temperature (137 °C), indicating that both 8 and 9 are chemo-selective catalysts for ring closing metathesis reactions.
View MoreContact:Tel:+86-29-88764861 Fax:+86-29-88764861
Address:Rm#2107, Block A, Epin Meidao Building, Gaoxin Rd, Hi-Tech Zone, Xi’an, China
Contact:+44 (0)161 367 9441
Address:
Nanjing Zelang Medical Technology Co. Ltd
Contact:86-25-83063290/13770714480
Address:Ganjiabian 108# 01 Unit,701-702 room,Yao Hua Street,Qixia District,Nanjing,Jiangsu,China
Tianjin Pharmacn Medical Technology Co.,Ltd.
Contact:86-22-60122566ext.866(English),23359620
Address:Green Industrial Base, 6 Haitaifazhan Sixth Rd., Huayuan Industrial Area, Tianjin, 300384, China
Contact:86-21-34622192,13917187091,21-34622765
Address:No. 500 Caobao Road Shanghai P.R China
Doi:10.1016/S0020-1693(00)80921-4
(1991)Doi:10.1002/jhet.5570280727
(1991)Doi:10.1021/jo900637f
(2009)Doi:10.1021/jm300818k
(2012)Doi:10.1016/0009-3084(66)90005-3
(1966)Doi:10.1248/cpb.15.1071
(1967)